Chapter 2 Human Total Serum N-Glycome

Advances in Clinical Chemistry

Volumn 46, Issue , 2008, Pages 51-85

  Klein, André ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; PLASMA PROTEIN;

BLOOD; GLYCOSYLATION; HUMAN; INFLAMMATION; LIVER CIRRHOSIS; MASS SPECTROMETRY; METABOLISM; NEOPLASM; REVIEW;

BLOOD PROTEINS; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; INFLAMMATION; LIVER CIRRHOSIS; NEOPLASMS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 53849126845     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2423(08)00402-2     Document Type: Review

References (119)

1. Raman R., Raguram S., Venkataraman G., Paulson J.C., and Sasisekharan R. Glycomics: An integrated systems approach to structure-function relationships of glycans. Nat Methods 2 (2005) 817-824
2. Spiro R.G. Protein glycosylation: Nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology 12 (2002) 43R-56R
3. Jaeken J., and Matthijs G. Congenital disorders of glycosylation: A rapidly expanding disease family. Annu Rev Genomics Hum Genet 8 (2007) 261-278
4. Varki A. Biological roles of oligosaccharides: All of the theories are correct. Glycobiology 3 (1993) 97-130
5. Klein A., Diaz S., Ferreira I., Lamblin G., Roussel P., and Manzi A.E. New sialic acids from biological sources identified by a comprehensive and sensitive approach: Liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) of SIA quinoxalinones. Glycobiology 7 (1997) 421-432
6. Kornfeld R., and Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 54 (1985) 631-664
7. Schachter H. Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. Biochem Cell Biol 64 (1986) 163-181
8. Abeijon C., Mandon E.C., and Hirschberg C.B. Transporters of nucleotide sugars, nucleotide sulfate and ATP in the Golgi apparatus. Trends Biochem Sci 22 (1997) 203-207
9. Wu X., Steet R.A., Bohorov O., Bakker J., et al. Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder. Nat Med 10 (2004) 518-523
10. Mizuochi T., Taniguchi T., Shimizu A., and Kobata A. Structural and numerical variations of the carbohydrate moiety of immunoglobulin G. J Immunol 129 (1982) 2016-2020
11. Parekh R.B., Dwek R.A., Sutton B.J., et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316 (1985) 452-457
12. Fujii S., Nishiura T., Nishikawa A., Miura R., and Taniguchi N. Structural heterogeneity of sugar chains in immunoglobulin G. Conformation of immunoglobulin G molecule and substrate specificities of glycosyltransferases. J Biol Chem 265 (1990) 6009-6018
13. Butler M., Quelhas D., Critchley A.J., et al. Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis. Glycobiology 13 (2003) 601-622
14. Arnold J.N., Wormald M.R., Sim R.B., Rudd P.M., and Dwek R.A. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol 25 (2007) 21-50
15. Malhotra R., Wormald M.R., Rudd P.M., Fischer P.B., Dwek R.A., and Sim R.B. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1 (1995) 237-243
16. Arnold J.N., Dwek R.A., Rudd P.M., and Sim R.B. Mannan binding lectin and its interaction with immunoglobulins in health and in disease. Immunol Lett 106 (2006) 103-110
17. Mimura Y., Sondermann P., Ghirlando R., et al. Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding. J Biol Chem 276 (2001) 45539-45547
18. Shinkawa T., Nakamura K., Yamane N., et al. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem. 278 (2003) 3466-3473
19. Kaneko Y., Nimmerjahn F., and Ravetch J.V. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313 (2006) 670-673
20. Scallon B.J., Tam S.H., McCarthy S.G., Cai A.N., and Raju T.S. Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. Mol Immunol 44 (2007) 1524-1534
21. Rook G.A., Onyebujoh P., Wilkins E., Ly H.M., al Attiyah R., Bahr G., Corrah T., Hernandez H., and Stanford J.L. A longitudinal study of per cent agalactosyl IgG in tuberculosis patients receiving chemotherapy, with or without immunotherapy. Immunology 81 (1994) 149-154
22. Rademacher T.W., Parekh R.B., and Dwek R.A. Glycobiology. Annu Rev Biochem 57 (1988) 785-838
23. Cremata J.A., Sorell L., Montesino R., et al. Hypogalactosylation of serum IgG in patients with coeliac disease. Clin Exp Immunol 133 (2003) 422-429
24. Novak J., Tomana M., Shah G.R., Brown R., and Mestecky J. Heterogeneity of IgG glycosylation in adult periodontal disease. J Dent Res 84 (2005) 897-901
25. Moore J.S., Wu X., Kulhavy R., Tomana M., et al. Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals. AIDS 19 (2005) 381-389
26. Holland M., Yagi H., Takahashi N., et al. Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis. Biochim Biophys Acta 176 (2006) 669-677
27. Kanoh Y., Mashiko T., Danbara M., et al. Changes in serum IgG oligosaccharide chains with prostate cancer progression. Anticancer Res 24 (2004) 3135-3139
28. Baenziger J., and Kornfeld S. Structure of the carbohydrate units of IgA1 immunoglobulin. I. Composition, glycopeptide isolation, and structure of the asparagine-linked oligosaccharide units. J Biol Chem 249 (1974) 7260-7269
29. Field M.C., Amatayakul-Chantler S., Rademacher T.W., Rudd P.M., and Dwek R.A. Structural analysis of the N-glycans from human immunoglobulin A1: Comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis. Biochem J 299 (1994) 261-275
30. Mattu T.S., Pleass R.J., Willis A.C., et al. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fc alpha receptor interactions. J Biol Chem 273 (1998) 2260-2272
31. Roos A., Bouwman L.H., van Gijlswijk-Janssen D.J., et al. Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol 167 (2001) 2861-2868
32. Rifai A., Fadden K., Morrison S.L., and Chintalacharuvu K.R. The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes. J Exp Med 191 (2000) 2171-2182
33. Oortwijn B.D., Roos A., Royle L., et al. Differential glycosylation of polymeric and monomeric IgA: A possible role in glomerular inflammation in IgA nephropathy. J Am Soc Nephrol 17 (2006) 3529-3539
34. Basset C., Durand V., Jamin C., et al. Increased N-linked glycosylation leading to oversialylation of monomeric immunoglobulin A1 from patients with Sjogren's syndrome. Scand J Immunol 51 (2000) 300-306
35. Chapman A., and Kornfeld R. Structure of the high mannose oligosaccharides of a human IgM myeloma protein. I. The major oligosaccharides of the two high mannose glycopeptides. J Biol Chem 254 (1979) 816-823
36. Chapman A., and Kornfeld R. Structure of the high mannose oligosaccharides of a human IgM myeloma protein. II. The minor oligosaccharides of high mannose glycopeptide. J Biol Chem 254 (1979) 824-828
37. Arnold J.N., Wormald M.R., Suter D.M., et al. Human serum IgM glycosylation: Identification of glycoforms that can bind to mannan-binding lectin. J Biol Chem 280 (2005) 29080-29087
38. Spik G., Bayard B., Fournet B., Strecker G., Bouquelet S., and Montreuil J. Studies on glycoconjugates. LXIV. Complete structure of two carbohydrate units of human serotransferrin. FEBS Lett 50 (1975) 296-299
39. Marz L., Hatton M.W., Berry L.R., and Regoeczi E. The structural heterogeneity of the carbohydrate moiety of desialylated human transferrin. Can J Biochem 60 (1982) 624-630
40. Flahaut C., Michalski J.C., Danel T., Humbert M.H., and Klein A. The effects of ethanol on the glycosylation of human transferrin. Glycobiology 13 (2003) 191-198
41. Hoefkens P., Huijskes-Heins M.I., de Jeu-Jaspars C.M., van Noort W.L., and van Eijk H.G. Influence of transferrin glycans on receptor binding and iron-donation. Glycoconj J 14 (1997) 289-295
42. Stibler H., Allgulander C., Borg S., and Kjellin K.G. Abnormal microheterogeneity of transferrin in serum and cerebrospinal fluid in alcoholism. Acta Med Scand 204 (1978) 49-56
43. Grunewald S., Matthijs G., and Jaeken J. Congenital disorders of glycosylation: A review. Pediatr Res 52 (2002) 618-624
44. Yamashita K., Koide N., Endo T., Iwaki Y., and Kobata A. Altered glycosylation of serum transferrin of patients with hepatocellular carcinoma. J Biol Chem 264 (1989) 2415-2423
45. De Jong G., Feelders R., Van Noort W.L., and Van Eijk H.G. Transferrin microheterogeneity as a probe in normal and disease states. Glycoconj J 12 (1995) 219-226
46. Sottrup-Jensen L. Alpha-macroglobulins: Structure, shape, and mechanism of proteinase complex formation. J Biol Chem 264 (1989) 11539-11542
47. Arnold J.N., Wallis R., Willis A.C., et al. Interaction of mannan binding lectin with alpha2 macroglobulin via exposed oligomannose glycans: A conserved feature of the thiol ester protein family. J Biol Chem 281 (2006) 6955-6963
48. Panzironi C., Silvestrini B., Mo M.Y., Lahita R., Mruk D., and Cheng C.Y. An increase in the carbohydrate moiety of alpha 2-macroglobulin is associated with systemic lupus erythematosus (SLE). Biochem Mol Biol Int 43 (1997) 1305-1322
49. Gunnarsson M., Stigbrand T., and Jensen P.E. Aberrant forms of alpha(2)-macroglobulin purified from patients with multiple sclerosis. Clin Chim Acta 295 (2000) 27-40
50. Kolarich D., Weber A., Turecek P.L., Schwarz H.P., and Altmann F. Comprehensive glyco-proteomic analysis of human alpha1-antitrypsin and its charge isoforms. Proteomics 6 (2006) 3369-3380
51. Jeppsson J.O., and Einarsson R. Genetic variants of alpha 1-antitrypsin and hemoglobin typed by isoelectric focusing in preselected narrow pH gradients with PhastSystem. Clin Chem 38 (1992) 577-580
52. Henry H., Froehlich F., Perret R., et al. Microheterogeneity of serum glycoproteins in patients with chronic alcohol abuse compared with carbohydrate-deficient glycoprotein syndrome type I. Clin Chem 45 (1999) 1408-1413
53. Hillebrand G., Schneppenheim R., Oldigs H.D., and Santer R. Hereditary fructose intolerance and alpha(1) antitrypsin deficiency. Arch Dis Child 83 (2000) 72-73
54. Mills P., Mills K., Clayton P., Johnson A., Whitehouse D., and Winchester B. Congenital disorders of glycosylation type I leads to altered processing of N-linked glycans, as well as underglycosylation. Biochem J 359 (2001) 249-254
55. Treuheit M.J., Costello C.E., and Halsall H.B. Analysis of the five glycosylation sites of human alpha 1-acid glycoprotein. Biochem J 283 (1992) 105-112
56. Wieruszeski J.M., Fournet B., Konan D., Biou D., and Durand G. 400-MHz 1H-NMR spectroscopy of fucosylated tetrasialyl oligosaccharides isolated from normal and cirrhotic alpha 1-acid glycoprotein. FEBS Lett 238 (1988) 390-394
57. Higai K., Aoki Y., Azuma Y., and Matsumoto K.R. Glycosylation of site-specific glycans of alpha1-acid glycoprotein and alterations in acute and chronic inflammation. Biochim Biophys Acta 1725 (2005) 128-135
58. Ceciliani F., and Pocacqua V. The acute phase protein alpha1-acid glycoprotein: A model for altered glycosylation during diseases. Curr Protein Pept Sci 8 (2007) 91-108
59. X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera. J Exp Med 177 (1993) 657-666
60. Havenaar E.C., Dolhain R.J., Turner G.A., et al. Do synovial fluid acute phase proteins from patients with rheumatoid arthritis originate from serum. Glycoconj J 14 (1997) 457-465
61. X on alpha 1-acid glycoprotein in females and male-to-female transsexuals. Glycobiology 6 (1996) 407-412
62. Wilson N.L., Schulz B.L., Karlsson N.G., and Packer N.H. Sequential analysis of N- and O-linked glycosylation of 2D-PAGE separated glycoproteins. J Proteome Res 1 (2002) 521-529
63. He Z., Aristoteli L.P., Kritharides L., and Garner B. HPLC analysis of discrete haptoglobin isoform N-linked oligosaccharides following 2D-PAGE isolation. Biochem Biophys Res Commun 343 (2006) 496-503
64. Goodarzi M.T., and Turner G.A. Reproducible and sensitive determination of charged oligosaccharides from haptoglobin by PNGase F digestion and HPAEC/PAD analysis: Glycan composition varies with disease. Glycoconj J 15 (1998) 469-475
65. Okuyama N., Ide Y., Nakano M., et al. Fucosylated haptoglobin is a novel marker for pancreatic cancer: A detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int J Cancer 118 (2006) 2803-2808
66. Yamashita K., Liang C.J., Funakoshi S., and Kobata A. Structural studies of asparagine-linked sugar chains of human ceruloplasmin. Structural characteristics of the triantennary complex type sugar chains of human plasma glycoproteins. J Biol Chem 256 (1981) 1283-1289
67. Endo M., Suzuki K., Schmid K., et al. The structures and microheterogeneity of the carbohydrate chains of human plasma ceruloplasmin. A study employing 500-MHz 1H-NMR spectroscopy. J Biol Chem 257 (1982) 8755-8760
68. Ritchie G.E., Moffatt B.E., Sim R.B., Morgan B.P., Dwek R.A., and Rudd P.M. Glycosylation and the complement system. Chem Rev 102 (2002) 305-319
69. Taniguchi T., Ishikawa Y., Tsunemitsu M., and Fukuzaki H. The structures of the asparagine-linked sugar chains of human apolipoprotein B-100. Arch Biochem Biophys 273 (1989) 197-205
70. Garner B., Harvey D.J., Royle L., et al. Characterization of human apolipoprotein B100 oligosaccharides in LDL subfractions derived from normal and hyperlipidemic plasma: Deficiency of alpha-N-acetylneuraminyllactosyl-ceramide in light and small dense LDL particles. Glycobiology 11 (2001) 791-802
71. Garner B., Merry A.H., Royle L., Harvey D.J., Rudd P.M., and Thillet J. Structural elucidation of the N- and O-glycans of human apolipoprotein(a): Role of o-glycans in conferring protease resistance. J Biol Chem 276 (2001) 22200-22208
72. Callewaert N., Geysens S., Molemans F., and Contreras R. Ultrasensitive profiling and sequencing of N-linked oligosaccharides using standard DNA-sequencing equipment. Glycobiology 11 (2001) 275-281
73. Callewaert N., Schollen E., Vanhecke A., Jaeken J., Matthijs G., and Contreras R. Increased fucosylation and reduced branching of serum glycoprotein N-glycans in all known subtypes of congenital disorder of glycosylation I. Glycobiology 13 (2003) 367-375
74. Callewaert N., Van Vlierberghe H., Van Hecke A., Laroy W., Delanghe J., and Contreras R. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med 10 (2004) 429-434
75. Callewaert N., Contreras R., Mitnik-Gankin L., Carey L., Matsudaira P., and Ehrlich D. Total serum protein N-glycome profiling on a capillary electrophoresis-microfluidics platform. Electrophoresis 25 (2004) 3128-3131
76. Patel T., Bruce J., Merry A., Bigge C., Wormald M., Jaques A., and Parekh R. Use of hydrazine to release in intact and unreduced form both N- and O-linked oligosaccharides from glycoproteins. Biochemistry 32 (1993) 679-693
77. Tarentino A.L., and Plummer Jr. T.H. Enzymatic deglycosylation of asparagine-linked glycans: Purification, properties, and specificity of oligosaccharide-cleaving enzymes from Flavobacterium meningosepticum. Methods Enzymol 230 (1994) 44-57
78. Nakagawa H., Hato M., Takegawa Y., et al. Detection of altered N-glycan profiles in whole serum from rheumatoid arthritis patients. J Chromatogr B Analyt 853 (2007) 133-137
79. Sagi D., Kienz P., Denecke J., Marquardt T., and Peter-Katalinic J. Glycoproteomics of N-glycosylation by in-gel deglycosylation and matrix-assisted laser desorption/ionisation-time of flight mass spectrometry mapping: Application to congenital disorders of glycosylation. Proteomics 5 (2005) 2689-2701
80. Kyselova Z., Mechref Y., Al Bataineh M.M., Dobrolecki L.E., Hickey R.J., Vinson J., et al. Alterations in the serum glycome due to metastatic prostate cancer. J Proteome Res 6 (2007) 1822-1832
81. Papac D.I., Briggs J.B., Chin E.T., and Jones A.J. A high-throughput microscale method to release N-linked oligosaccharides from glycoproteins for matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis. Glycobiology 8 (1998) 445-454
82. Kam R.K., Poon T.C., Chan H.L., Wong N., Hui A.Y., and Sung J.J. High-throughput quantitative profiling of serum N-glycome by MALDI-TOF mass spectrometry and N-glycomic fingerprint of liver fibrosis. Clin Chem 53 (2007) 1254-1263
83. Morelle W., Flahaut C., Michalski J.C., Louvet A., Mathurin P., and Klein A. Mass spectrometric approach for screening modifications of total serum N-glycome in human diseases: Application to cirrhosis. Glycobiology 16 (2006) 281-293
84. Packer N.H., Lawson M.A., Jardine D.R., and Redmond J.W. A general approach to desalting oligosaccharides released from glycoproteins. Glycoconj J 15 (1998) 737-747
85. Powell A.K., and Harvey D.J. Stabilization of sialic acids in N-linked oligosaccharides and gangliosides for analysis by positive ion matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom 10 (1996) 1027-1032
86. Varki A., and Diaz S. The release and purification of sialic acids from glycoconjugates: Methods to minimize the loss and migration of O-acetyl groups. Anal Biochem 137 (1984) 236-247
87. Harvey D.J. Matrix-assisted laser desorption/ionization mass spectrometry of carbohydrates. Mass Spectrom Rev 18 (1999) 349-450
88. Wada Y., Azadi P., Costello C.E., et al. Comparison of the methods for profiling glycoprotein glycans-HUPO human disease glycomics/proteome initiative multi-institutional study. Glycobiology 17 (2007) 411-422
89. Ciucanu I., and Kerek F. A simple and rapid method for the permethylation of carbohydrates. Carbohydr Res 131 (1984) 209-217
90. Morelle W., and Michalski J.C. Analysis of protein glycosylation by mass spectrometry. Nat Protoc 2 7 (2007) 1585-1602
91. Weiskopf A.S., Vouros P., and Harvey D.J. Electrospray ionization-ion trap mass spectrometry for structural analysis of complex N-linked glycoprotein oligosaccharides. Anal Chem 70 (1998) 4441-4447
92. Albersheim P., Nevins D.J., English P.D., and Karr A. A method for the analysis of sugars in plant cell wall polysaccharides by gas-liquid chromatography. Carbohydr Res 5 (1967) 340-345
93. Jackson P. High-resolution polyacrylamide gel electrophoresis of fluorophore-labeled reducing saccharides. Methods Enzymol 230 (1994) 250-265
94. Laroy W., Contreras R., and Callewaert N. Glycome mapping on DNA sequencing equipment. Nat Protoc 1 1 (2006) 397-405
95. Hase S. High-performance liquid chromatography of pyridylaminated saccharides. Methods Enzymol 230 (1994) 225-237
96. Nakagawa H., Kawamura Y., Kato K., Shimada I., Arata Y., and Takahashi N. Identification of neutral and sialyl N-linked oligosaccharide structures from human serum glycoproteins using three kinds of high-performance liquid chromatography. Anal Biochem 226 (1995) 130-138
97. Kita Y., Miura Y., Furukawa J.I., et al. Quantitative glycomics of human whole serum glycoproteins based on the standardized protocol for liberating N-glycans. Mol Cell Proteomics 6 (2007) 1437-1445
98. Parekh R., Roitt I., Isenberg D., Dwek R., and Rademacher T. Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med 167 (1988) 1731-1736
99. Gravel P., Walzer C., Aubry C., et al. New alterations of serum glycoproteins in alcoholic and cirrhotic patients revealed by high resolution two-dimensional gel electrophoresis. Biochem Biophys Res Commun 220 (1996) 78-85
100. Ryden I., Pahlsson P., and Lindgren S. Diagnostic accuracy of alpha(1)-acid glycoprotein fucosylation for liver cirrhosis in patients undergoing hepatic biopsy. Clin Chem 48 (2002) 2195-2201
101. Anderson N., Pollacchi A., Hayes P., et al. A preliminary evaluation of the differences in the glycosylation of alpha-1-acid glycoprotein between individual liver diseases. Biomed Chromatogr 16 (2002) 365-372
102. Paradis V. Glycomics: A new taste of cirrhosis marker. J Hepatol 43 (2005) 913-914
103. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999) 448-454
104. van Dijk W., Brinkman-van der Linden E.C., and Havenaar E.C. Glycosylation of alpha 1-acid glycoprotein (orosomucoid) in health and disease: Occurrence, regulation and possible functional implications. Trends Glycosci Glycotechnol 10 (1998) 235-245
105. Thompson S., Kelly C.A., Griffiths I.D., and Turner G.A. Abnormally-fucosylated serum haptoglobins in patients with inflammatory joint disease. Clin Chim Acta 184 (1989) 251-258
106. Hachulla E., Laine A., and Hayem A. Alpha 1-antichymotrypsin microheterogeneity in crossed immunoaffinoelectrophoresis with free concanavalin A: A useful diagnostic tool in inflammatory syndrome. Clin Chem 34 (1988) 911-915
107. Ang I.L., Poon T.C., Lai P.B., et al. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: A glycoproteomic approach. J Proteome Res 5 (2006) 2691-2700
108. Hashimoto S., Asao T., Takahashi J., et al. alpha1-acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis. Cancer 101 (2004) 2825-2836
109. Van Dijk W., Koeleman C., Van het Hof B., Poland D., Jakobs C., and Jaeken J. Increased alpha3-fucosylation of alpha(1)-acid glycoprotein in patients with congenital disorder of glycosylation type IA (CDG-Ia). FEBS Lett 494 (2001) 232-235
110. Coddeville B., Carchon H., Jaeken J., Briand G., and Spik G. Determination of glycan structures and molecular masses of the glycovariants of serum transferrin from a patient with carbohydrate deficient syndrome type II. Glycoconj J 15 (1998) 265-273
111. Faid V., Chirat F., Seta N., Foulquier F., and Morelle W. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis. Proteomics 7 (2007) 1800-1813
112. Foulquier F., Vasile E., Schollen E., et al. Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II. Proc Natl Acad Sci USA 103 (2006) 3764-3769
113. Sturiale L., Barone R., Fiumara A., et al. Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia. Glycobiology 15 (2005) 1268-1276
114. Larsson A., Flodin M., and Kollberg H. Increased serum concentrations of carbohydrate-deficient transferrin (CDT) in patients with cystic fibrosis. Ups J Med Sci 103 (1998) 231-236
115. Huang L., Harvie G., Feitelson J.S., et al. Immunoaffinity separation of plasma proteins by IgY microbeads: Meeting the needs of proteomic sample preparation and analysis. Proteomics 5 (2005) 3314-3328
116. Echan L.A., Tang H.Y., Ali-Khan N., Lee K., and Speicher D.W. Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. Proteomics 5 (2005) 3292-3303
117. Klein A., Lebreton A., Lemoine J., Perini J.M., Roussel P., and Michalski J.C. Identification of urinary oligosaccharides by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Chem 44 (1998) 2422-2428
118. Neville D.C., Coquard V., Priestman D.A., et al. Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling. Anal Biochem 331 (2004) 275-282
119. An H.J., Miyamoto S., Lancaster K.S., Kirmiz C., Li B., Lam K.S., Leiserowitz G.S., and Lebrilla C.B. Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. J Proteome Res 5 (2006) 1626-1635